Clinical impact using low-dose mycophenolate mofetil with tacrolimus on infectious, noninfectious complications and acute rejection, in renal transplant: A single hospital experience in Mexico

Evidence supporting a starting dose of 2 g/day of mycophenolate mofetil (MMF) in combination with tacrolimus (TAC) for renal transplantation (RT) is still limited, but maintaining a dose of <2 g could result in worse clinical outcomes in terms of acute rejection (AR). This study aimed to determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade-Sierra, Jorge, Hernández-Reyes, Hernesto, Rojas-Campos, Enrique, Cardona-Muñoz, Ernesto Germán, Cerrillos-Gutiérrez, José Ignacio, González-Espinoza, Eduardo, Evangelista-Carrillo, Luis Alberto, Medina-Pérez, Miguel, Jalomo-Martínez, Basilio, Miranda-Díaz, Alejandra Guillermina, Martínez-Mejía, Víctor Manuel, Gómez-Navarro, Benjamin, Andrade-Ortega, Antonio de Jesús, Nieves-Hernández, Juan José, Mendoza-Cerpa, Claudia Alejandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659689/
https://www.ncbi.nlm.nih.gov/pubmed/37986377
http://dx.doi.org/10.1097/MD.0000000000035841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659689/
https://www.ncbi.nlm.nih.gov/pubmed/37986377
http://dx.doi.org/10.1097/MD.0000000000035841

Ejemplares similares